4//SEC Filing
Stecyk Chrystyna Bedrij 4
Accession 0001062993-24-010181
CIK 0001205922other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:32 PM ET
Size
11.0 KB
Accession
0001062993-24-010181
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Stecyk Chrystyna Bedrij
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-10+10,108→ 10,108 totalExercise: $5.75From: 2025-05-10→ Common Stock (10,108 underlying)
Holdings
- 684
Stock Option (Right to Buy)
Exercise: $86.10From: 2024-05-11→ Common Stock (684 underlying) - 253
Stock Option (Right to Buy)
Exercise: $235.20From: 2023-05-12→ Common Stock (253 underlying) - 119
Stock Option (Right to Buy)
Exercise: $829.50From: 2021-05-14→ Common Stock (119 underlying) - 136
Stock Option (Right to Buy)
Exercise: $451.50From: 2022-05-11→ Common Stock (136 underlying)
Footnotes (5)
- [F1]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- [F2]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
- [F3]This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
- [F4]This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
- [F5]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first.
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001811625
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:32 PM ET
- Size
- 11.0 KB